Medica Group PLC Director/PDMR Shareholding (0950F)
05 Julio 2023 - 9:39AM
UK Regulatory
TIDMMGP
RNS Number : 0950F
Medica Group PLC
05 July 2023
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 4 July 2023,
the PDMRs listed below had options that vested and were exercised
due to the approval of Scheme of Arrangement via Court Sanction
hearing. The exercised options were ordinary shares of 0.2p each in
the Company under the Company's Performance Share Plan 2017,
Deferred Bonus Plan 2017 and Save As You Earn Scheme:
Name of PDMR Number of shares subject to options
Stuart Quin 744,671
Richard Jones 545,399
Kevin Terrins 284,292
Sarah Burns 226,457
Marc O'Brien 288,130
Caroline Byrne 139,141
Rob Lavis 193,342
Fiona Carr 43,780
Kim Scanlan 32,905
The notifications set out below are provided in accordance with
the requirements of the UK Market Abuse Regulation, and set out
more details of the transactions.
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
-------------------------- ---------------------------------------------------------
2. Reason for notification
-------------------------------------------------------------------------------------
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
-------------------------- ---------------------------------------------------------
Initial notification Initial notification in each case
/ amendment
-------------------------- ---------------------------------------------------------
3. Details of the Issuer
-------------------------------------------------------------------------------------
(a) Name Medica Group PLC
-------------------------- ---------------------------------------------------------
(b) LEI 213800B8XE5FUSZF5Z16
-------------------------- ---------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
have been conducted
-------------------------------------------------------------------------------------
(a) Description of Ordinary shares of 0.2p each in the
the financial instrument capital of the Company ("Shares")
-------------------------- ---------------------------------------------------------
(b) Nature of the transaction Vesting and exercise of options over
Shares pursuant to the Company's Performance
Share Plan 2017
-------------------------- ---------------------------------------------------------
(c) Price(s) and volume GBPNil Option Price in each case
1. 597,579
2. 454,832
3. 217,565
4. 175,869
5. 212,516
6. 85,323
7. 154,811
8. 37,141
9. 32,905
-------------------------- ---------------------------------------------------------
(d) Aggregated information N/A
-------------------------- ---------------------------------------------------------
(e) Date of the transaction 4 July 2023
-------------------------- ---------------------------------------------------------
(f) Place of the transaction Outside a trading venue
-------------------------- ---------------------------------------------------------
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
-------------------------- ---------------------------------------------------------
2. Reason for notification
-------------------------------------------------------------------------------------
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
-------------------------- ---------------------------------------------------------
Initial notification Initial notification in each case
/ amendment
-------------------------- ---------------------------------------------------------
3. Details of the Issuer
-------------------------------------------------------------------------------------
(a) Name Medica Group PLC
-------------------------- ---------------------------------------------------------
(b) LEI 213800B8XE5FUSZF5Z16
-------------------------- ---------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
have been conducted
-------------------------------------------------------------------------------------
(a) Description of Ordinary shares of 0.2p each in the
the financial instrument capital of the Company ("Shares")
-------------------------- ---------------------------------------------------------
(b) Nature of the transaction Vesting and exercise of options over
Shares pursuant to the Deferred Bonus
Plan 2017
-------------------------- ---------------------------------------------------------
(c) Price(s) and volume GBPNil Option Price in each case
1. 129,092
2. 82,006
3. 48,727
4. 42,027
5. 57,614
6. 53,818
7. 35,107
8. 5,725
9. -
-------------------------- ---------------------------------------------------------
(d) Aggregated information N/A
-------------------------- ---------------------------------------------------------
(e) Date of the transaction 4 July 2023
-------------------------- ---------------------------------------------------------
(f) Place of the transaction Outside a trading venue
-------------------------- ---------------------------------------------------------
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
-------------------------- ---------------------------------------------------------
2. Reason for notification
-------------------------------------------------------------------------------------
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
-------------------------- ---------------------------------------------------------
Initial notification Initial notification in each case
/ amendment
-------------------------- ---------------------------------------------------------
3. Details of the Issuer
-------------------------------------------------------------------------------------
(a) Name Medica Group PLC
-------------------------- ---------------------------------------------------------
(b) LEI 213800B8XE5FUSZF5Z16
-------------------------- ---------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
have been conducted
-------------------------------------------------------------------------------------
(a) Description of Ordinary shares of 0.2p each in the
the financial instrument capital of the Company ("Shares")
-------------------------- ---------------------------------------------------------
(b) Nature of the transaction Vesting and exercise of options over
Shares pursuant to the Save As Your
Earn Scheme 2020
-------------------------- ---------------------------------------------------------
(c) Price(s) and volume GBP1.00 Option Price in each case
1. 18,000
2. -
3. 18,000
4. -
5. 18,000
6. -
7. -
8. -
9. -
-------------------------- ---------------------------------------------------------
(d) Aggregated information N/A
-------------------------- ---------------------------------------------------------
(e) Date of the transaction 4 July 2023
-------------------------- ---------------------------------------------------------
(f) Place of the transaction Outside a trading venue
-------------------------- ---------------------------------------------------------
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
-------------------------- ---------------------------------------------------------
2. Reason for notification
-------------------------------------------------------------------------------------
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
-------------------------- ---------------------------------------------------------
Initial notification Initial notification in each case
/ amendment
-------------------------- ---------------------------------------------------------
3. Details of the Issuer
-------------------------------------------------------------------------------------
(a) Name Medica Group PLC
-------------------------- ---------------------------------------------------------
(b) LEI 213800B8XE5FUSZF5Z16
-------------------------- ---------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
have been conducted
-------------------------------------------------------------------------------------
(a) Description of Ordinary shares of 0.2p each in the
the financial instrument capital of the Company ("Shares")
-------------------------- ---------------------------------------------------------
(b) Nature of the transaction Vesting and exercise of options over
Shares pursuant to the Save As Your
Earn Scheme 2021
-------------------------- ---------------------------------------------------------
(c) Price(s) and volume GBP1.46 Option Price in each case
1. -
2. 8,561
3. -
4. 8,561
5. -
6. -
7. 3,424
8. -
9. -
-------------------------- ---------------------------------------------------------
(d) Aggregated information N/A
-------------------------- ---------------------------------------------------------
(e) Date of the transaction 4 July 2023
-------------------------- ---------------------------------------------------------
(f) Place of the transaction Outside a trading venue
-------------------------- ---------------------------------------------------------
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
-------------------------- ---------------------------------------------------------
2. Reason for notification
-------------------------------------------------------------------------------------
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
-------------------------- ---------------------------------------------------------
Initial notification Initial notification in each case
/ amendment
-------------------------- ---------------------------------------------------------
3. Details of the Issuer
-------------------------------------------------------------------------------------
(a) Name Medica Group PLC
-------------------------- ---------------------------------------------------------
(b) LEI 213800B8XE5FUSZF5Z16
-------------------------- ---------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
have been conducted
-------------------------------------------------------------------------------------
(a) Description of Ordinary shares of 0.2p each in the
the financial instrument capital of the Company ("Shares")
-------------------------- ---------------------------------------------------------
(b) Nature of the transaction Vesting and exercise of options over
Shares pursuant to the Save As Your
Earn Scheme 2022
-------------------------- ---------------------------------------------------------
(c) Price(s) and volume GBP1.422 Option Price in each case
1. -
2. -
3. -
4. -
5. -
6. -
7. -
8. 914
9. -
-------------------------- ---------------------------------------------------------
(d) Aggregated information N/A
-------------------------- ---------------------------------------------------------
(e) Date of the transaction 4 July 2023
-------------------------- ---------------------------------------------------------
(f) Place of the transaction Outside a trading venue
-------------------------- ---------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHNKPBNQBKDPOK
(END) Dow Jones Newswires
July 05, 2023 10:39 ET (14:39 GMT)
Medica (LSE:MGP)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Medica (LSE:MGP)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
